• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4602597)   Today's Articles (693)   Subscriber (49368)
For: Pinel S, Chastagner P, Merlin JL, Marchal C, Taghian A, Barberi-Heyob M. Topotecan Can Compensate for Protracted Radiation Treatment Time Effects in High Grade Glioma Xenografts*. J Neurooncol 2005;76:31-8. [PMID: 16311843 DOI: 10.1007/s11060-005-3666-6] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Number Cited by Other Article(s)
1
Senbabaoglu F, Aksu AC, Cingoz A, Seker-Polat F, Borklu-Yucel E, Solaroglu İ, Bagci-Onder T. Drug Repositioning Screen on a New Primary Cell Line Identifies Potent Therapeutics for Glioblastoma. Front Neurosci 2021;14:578316. [PMID: 33390879 PMCID: PMC7773901 DOI: 10.3389/fnins.2020.578316] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/30/2020] [Accepted: 11/18/2020] [Indexed: 12/15/2022]  Open
2
Eyvazzadeh N, Neshasteh-Riz A, Mahdavi SR. DNA damage of glioblastoma multiform cells induced by Beta radiation of iodine-131 in the presence or absence of topotecan: a picogreen and colonogenic assay. CELL JOURNAL 2015;17:99-110. [PMID: 25870839 PMCID: PMC4393677 DOI: 10.22074/cellj.2015.516] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 10/12/2013] [Accepted: 02/08/2014] [Indexed: 11/20/2022]
3
Sabbatino F, Fusciello C, Somma D, Pacelli R, Poudel R, Pepin D, Leonardi A, Carlomagno C, Della Vittoria Scarpati G, Ferrone S, Pepe S. Effect of p53 activity on the sensitivity of human glioblastoma cells to PARP-1 inhibitor in combination with topoisomerase I inhibitor or radiation. Cytometry A 2014;85:953-61. [PMID: 25182801 DOI: 10.1002/cyto.a.22563] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/25/2014] [Revised: 08/09/2014] [Accepted: 08/13/2014] [Indexed: 01/19/2023]
4
Phenomenological modeling of tumor diameter growth based on a mixed effects model. J Theor Biol 2009;262:544-52. [PMID: 19835891 DOI: 10.1016/j.jtbi.2009.10.008] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/03/2009] [Revised: 10/06/2009] [Accepted: 10/07/2009] [Indexed: 12/11/2022]
5
Grabenbauer GG, Gerber KD, Ganslandt O, Richter A, Klautke G, Birkmann J, Meyer M. Effects of Concurrent Topotecan and Radiation on 6-Month Progression-Free Survival in the Primary Treatment of Glioblastoma Multiforme. Int J Radiat Oncol Biol Phys 2009;75:164-9. [DOI: 10.1016/j.ijrobp.2009.04.015] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/27/2008] [Revised: 04/09/2009] [Accepted: 04/10/2009] [Indexed: 11/17/2022]
6
Lesimple T, Riffaud L, Frappaz D, Ben Hassel M, Gédouin D, Bay JO, Linassier C, Hamlat A, Piot G, Fabbro M, Saïkali S, Carsin B, Guégan Y. Topotecan in combination with radiotherapy in unresectable glioblastoma: a phase 2 study. J Neurooncol 2009;93:253-60. [PMID: 19139825 DOI: 10.1007/s11060-008-9774-3] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/08/2008] [Accepted: 12/16/2008] [Indexed: 12/17/2022]
7
Gerstner ER, Fine RL. Increased permeability of the blood-brain barrier to chemotherapy in metastatic brain tumors: establishing a treatment paradigm. J Clin Oncol 2007;25:2306-12. [PMID: 17538177 DOI: 10.1200/jco.2006.10.0677] [Citation(s) in RCA: 189] [Impact Index Per Article: 11.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open
8
Kremer S, Pinel S, Védrine PO, Bressenot A, Robert P, Bracard S, Plénat F. Ferumoxtran-10 enhancement in orthotopic xenograft models of human brain tumors: an indirect marker of tumor proliferation? J Neurooncol 2007;83:111-9. [PMID: 17443290 DOI: 10.1007/s11060-006-9260-8] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/11/2005] [Accepted: 08/30/2006] [Indexed: 10/23/2022]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA